Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
J Chem Inf Model ; 50(5): 732-41, 2010 May 24.
Article in English | MEDLINE | ID: mdl-20405959

ABSTRACT

A wide range of data on sequences, structures, pathways, and networks of genes and gene products is available for hypothesis testing and discovery in biological and biomedical research. However, data describing the physical, chemical, and biological properties of small molecules have not been well-integrated with these resources. Semantically rich representations of chemical data, combined with Semantic Web technologies, have the potential to enable the integration of small molecule and biomolecular data resources, expanding the scope and power of biomedical and pharmacological research. We employed the Semantic Web technologies Resource Description Framework (RDF) and Web Ontology Language (OWL) to generate a Small Molecule Ontology (SMO) that represents concepts and provides unique identifiers for biologically relevant properties of small molecules and their interactions with biomolecules, such as proteins. We instanced SMO using data from three public data sources, i.e., DrugBank, PubChem and UniProt, and converted to RDF triples. Evaluation of SMO by use of predetermined competency questions implemented as SPARQL queries demonstrated that data from chemical and biomolecular data sources were effectively represented and that useful knowledge can be extracted. These results illustrate the potential of Semantic Web technologies in chemical, biological, and pharmacological research and in drug discovery.


Subject(s)
Computational Biology/methods , Drug Discovery , Information Storage and Retrieval/methods , Database Management Systems , Internet , Natural Language Processing , Semantics
2.
Psychoneuroendocrinology ; 38(9): 1553-64, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23411461

ABSTRACT

The prevalence of childhood obesity has risen dramatically and coincident with this upsurge is a growth in adverse childhood psychological conditions including impulsivity, depression, anxiety and attention deficit/hyperactive disorder (ADHD). Due to confounds that exist when determining causality of childhood behavioral perturbations, controversy remains as to whether overnutrition and/or childhood obesity is important. Therefore, we examined juvenile mice to determine if biobehaviors were impacted by a short-term feeding (1-3wks) of a high-fat diet (HFD). After 1wk of a HFD feeding, mouse burrowing and spontaneous wheel running were increased while mouse exploration of the open quadrants of a zero maze, perfect alternations in a Y-maze and recognition of a novel object were impaired. Examination of mouse cortex, hippocampus and hypothalamus for dopamine and its metabolites demonstrated increased homovanillic acid (HVA) concentrations in the hippocampus and cortex that were associated with decreased cortical BDNF gene expression. In contrast, pro-inflammatory cytokine gene transcripts and serum IL-1α, IL-1ß, TNF-α and IL-6 were unaffected by the short-term HFD feeding. Administration to mice of the psychostimulant methylphenidate prevented HFD-dependent impairment of learning/memory. HFD learning/memory impairment was not inhibited by the anti-depressants desipramine or reboxetine nor was it blocked in IDO or IL-1R1 knockout mice. In sum, a HFD rapidly impacts dopamine metabolism in the brain appearing to trigger anxiety-like behaviors and learning/memory impairments prior to the onset of weight gain and/or pre-diabetes. Thus, overnutrition due to fats may be central to childhood psychological perturbations such as anxiety and ADHD.


Subject(s)
Central Nervous System Stimulants/therapeutic use , Dietary Fats/adverse effects , Learning Disabilities/prevention & control , Memory Disorders/prevention & control , Methylphenidate/therapeutic use , Overnutrition/psychology , 3,4-Dihydroxyphenylacetic Acid/analysis , Animals , Antidepressive Agents/pharmacology , Anxiety/etiology , Anxiety/prevention & control , Blood Glucose/analysis , Body Weight/drug effects , Brain-Derived Neurotrophic Factor/biosynthesis , Brain-Derived Neurotrophic Factor/genetics , Central Nervous System Stimulants/pharmacology , Cerebral Cortex/chemistry , Cerebral Cortex/drug effects , Cerebral Cortex/physiopathology , Cytokines/biosynthesis , Cytokines/genetics , Desipramine/pharmacology , Dopamine/analysis , Exploratory Behavior/drug effects , Gene Expression Regulation/drug effects , Hippocampus/chemistry , Hippocampus/drug effects , Hippocampus/physiopathology , Homovanillic Acid/analysis , Indoleamine-Pyrrole 2,3,-Dioxygenase/deficiency , Learning Disabilities/chemically induced , Male , Maze Learning/drug effects , Memory Disorders/chemically induced , Methylphenidate/pharmacology , Mice , Mice, Knockout , Monoamine Oxidase/analysis , Morpholines/pharmacology , Motor Activity/drug effects , Overnutrition/physiopathology , Physical Endurance/drug effects , Reboxetine , Receptors, Interleukin-1 Type I , Recognition, Psychology/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL